Navigation Links
Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Date:8/19/2007

Company's TPM-02/Insulin Significantly Lowered Blood Glucose without

Producing Any Adverse Reactions Phase 2 Trial Expected to Begin upon Ethics Approval with Results due in Q1

2008

MELBOURNE, Australia, Aug. 8 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH, AIM: PSG, OTCQX: PPGNY) today announced the successful completion of a Phase 1b transdermal insulin trial. The positive results of the trial demonstrated the ability of the Company's TPM technology to deliver insulin into the bloodstream in a non-invasive manner without causing any adverse events. Phosphagenics' TPM-02/Insulin formulation is being developed as a novel "needle-free" way of administering insulin to patients with diabetes.

The Phase 1b clinical trial, conducted at the Royal Adelaide Hospital in South Australia by CMAX, an independent clinical research organization, assessed the efficacy and safety of two TPM/Insulin formulations in 45 volunteers. Blood glucose, endogenous insulin and C-peptide levels were measured to assess efficacy.

Dr. Esra Ogru, Executive Vice President of Research and Development at Phosphagenics, said: "The Phase 1b trial showed that our TPM/Insulin formulation safely penetrated through the human skin and delivered insulin into the bloodstream over a sustained period of time, without causing adverse reactions."

"We believe that these results are indicative of Phosphagenics' potential to provide the millions of insulin-dependent diabetics with a non-intrusive alternative to multiple needle injections each day," said Dr. Ogru.

Phosphagenics intends to continue clinical development of its transdermal insulin. Preparations are underway for a Phase 2 trial to be conducted by CMAX at the Royal Adelaide Hospital under the guidance and supervision of Associate Professor William Hsu of the Joslin Diabetes Centre (Harvard Medical School) and Dr. Sepehr Shakib
'/>"/>

SOURCE Phosphagenics Limited

Copyright©2007 PR Newswire.

Page: 1 2 3

Related medicine technology :

1. Phosphagenics Announces Positive Proof of Concept Results from Studies Utilizing Companys Dermal Drug Delivery Technology
2. Phosphagenics to Commence Phase 1b Transdermal Insulin Clinical Trial in Second Quarter
3. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
4. Sygnis Pharma AG announces date for presentation of clinical results
5. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
7. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
8. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
9. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
10. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
11. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)...  Over the next five years, the marijuana industry in ... predicting that 14 more states will legalize recreational marijuana and ... for legal cannabis grew 74 percent in 2014 to $2.7 ... market could grow more than fourfold to $11 billion in ... on marijuana. Cannabiz Mobile Inc. (OTCBB: LGBI) is ...
(Date:4/17/2015)... Today, the Pharmaceutical Research and Manufacturers ... biopharmaceutical companies as "We Work For Health Champions" ... community service. Established in 2009, the ... by the biopharmaceutical industry to honor employees who ... have also shown an outstanding commitment to their ...
(Date:4/17/2015)...   IBA Molecular, a global leader in ... it has signed a definitive agreement to sell its ... to Illinois Health and Science (IHS). Under IHS ownership, IBAM ... headquartered in Dulles, Virginia , and ... product and footprint synergies. IBA Molecular is jointly owned ...
Breaking Medicine Technology:Cannabiz Mobile Analyst Brief: Next Big Thing by Torus IR Issued by BrokerBank Securities, Inc. 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 2PhRMA Applauds 2015 We Work For Health Champion Award Winners 3Health Care System to Acquire IBA Molecular North America 2Health Care System to Acquire IBA Molecular North America 3
... Provider Network presented checks totaling $80,000 to the two ... the Strata Conference in Santa Clara, California. The global ... Once again, the team of "Market Makers" ... Players include David Vogel, CEO and Chief Scientist of ...
... Food and Drug Administration (FDA) has cleared InTone™, a ... "InTone is a true medical breakthrough, and welcome ... issues," said Herschel "Buzz" Peddicord, president & CEO of ... we believe we can effectively treat this condition in ...
Cached Medicine Technology:Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 2Heritage Provider Network Awards $80,000 to the Progress Prize Winners in the $3Million Heritage Health Prize Contest at the Strata Conference in Santa Clara, California 3Medical Breakthrough for Incontinence From InControl Medical, LLC Cleared by FDA 2
(Date:4/17/2015)... (PRWEB) April 17, 2015 In Defense ... the following statement: “On Wednesday April 15th, the European ... adopted a resolution recognizing the Armenian Genocide, “paying tribute, ... of the one-and-a-half million innocent Armenian victims who perished ... (IDC) extols the EU for this timely and needed ...
(Date:4/17/2015)... Rapids, MI (PRWEB) April 17, 2015 Enthusiasts ... CRUSH Grand Rapids, Saturday, April 25, 2015. The event will ... Reserve Wine & Food (201 Monroe Ave NW, Grand Rapids, ... from around the West Michigan area. Patrons are encouraged to ... of elegance and fun. , This year’s event will feature ...
(Date:4/17/2015)... 2015 Most dental patients are not ... are made overseas by foreign dental laboratories, according to ... unregulated in more than 40 states by their respective ... of Dental Laboratories has created the “What’s ... patients about the consequences that could be associated with ...
(Date:4/17/2015)... Organic Valley, the nation’s largest cooperative ... International Year of Soils by “Cycling for Sustainability” through ... employees will travel 215 miles from Auburn, California, to ... about the impact of agriculture on water and soil ... Maine, Wisconsin, Oregon, and Washington state, the cyclists have ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Connie Casad, ... and functional medicine advocate with 30 years of practice ... be adding another level of service for her patients ... website of 10 recommended wellness books with a brief ... asked to explain her interest in providing this service, ...
Breaking Medicine News(10 mins):Health News:In Defense of Christians Condemns Armenian Genocide 2Health News:In Defense of Christians Condemns Armenian Genocide 3Health News:Children’s Leukemia Foundation of Michigan Presents 3rd Annual CRUSH Grand Rapids 2Health News:National Association Urges Transparency in Dental Industry 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 2Health News:Organic Valley Farmers and Employees "Cycling for Sustainability" Through 215 Miles of California Watershed April 19-25 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2
... 30% of all human cancer tumors, the Ras protein literally ... the Faculty of Life Sciences at Tel Aviv University. Prof. ... effective anti-Ras drug against pancreatic cancer, currently in clinical trials. ... European Journal of Pharmacology shows that the drug might be ...
... ... Conference Attendees: "We have no choice but to embrace our role as true reformers" ... Boston, MA ... (NACDS) President and CEO Steven C. Anderson, IOM, CAE, urged the 2009 Pharmacy & ...
... DALLAS, Aug. 10 The Fountain of Life Group was ... Fame unveiled its official 2009 Pro Football Hall of Fame Yearbook. ... ceremony as part of their support of the Hall,s flagship publication. ... of 1985 Hall of Famer Roger Staubach. , , ...
... Whether finding applies to today,s treatments remains unclear, experts ... at low doses, radiation therapy for low-grade brain tumors ... study reports. , Radiation is the most widely used ... most common type of brain cancer. , Researchers in ...
... , , , ... make known its response to recent criticism regarding President Obama,s nomination of ... Critics have suggested that because Dr. Benjamin is overweight, this sends the ... America,s health initiatives. , , A person,s body weight ...
... CONSHOHOCKEN, Pa., Aug. 10 The unique circumstances ... major role in decisions regarding security staffing, according to a ... ( All i edBarto n ... quality of service, professionalism and cost were cited as important ...
Cached Medicine News:Health News:Taking the needle's sting out of diabetes 2Health News:Anderson: Industry Advocacy, Engagement Key to Healthcare Reform 2Health News:Anderson: Industry Advocacy, Engagement Key to Healthcare Reform 3Health News:Anderson: Industry Advocacy, Engagement Key to Healthcare Reform 4Health News:Fountain of Life Group Debuts VaNu at the Pro Football Hall of Fame Enshrinement Weekend 2Health News:Radiation for Brain Tumors May Affect Cognition 2Health News:The Obesity Society Position on Recent Criticism of Surgeon General Nominee Regina Benjamin 2Health News:New Survey Identifies Specialized Training and Respect for Culture as Key Factors in Healthcare Security Personnel Selection 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: